These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9403584)

  • 21. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
    Van den Buuse M
    Eur J Pharmacol; 1993 Oct; 243(2):169-77. PubMed ID: 8276066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of dopamine receptors on lymphocytes in Parkinson's disease.
    Barbanti P; Fabbrini G; Ricci A; Cerbo R; Bronzetti E; Caronti B; Calderaro C; Felici L; Stocchi F; Meco G; Amenta F; Lenzi GL
    Mov Disord; 1999 Sep; 14(5):764-71. PubMed ID: 10495037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and L-DOPA treatment.
    Hurley MJ; Jolkkonen J; Stubbs CM; Jenner P; Marsden CD
    Brain Res; 1996 Feb; 709(2):259-64. PubMed ID: 8833762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats.
    Millan MJ; Audinot V; Rivet JM; Gobert A; Vian J; Prost JF; Spedding M; Peglion JL
    Eur J Pharmacol; 1994 Aug; 260(2-3):R3-5. PubMed ID: 7988633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
    Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
    Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus properties of 7-OH-DPAT, a dopamine D3-selective receptor ligand.
    McElroy JF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):531-3. PubMed ID: 7916465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand.
    Damsma G; Bottema T; Westerink BH; Tepper PG; Dijkstra D; Pugsley TA; MacKenzie RG; Heffner TG; Wikström H
    Eur J Pharmacol; 1993 Nov; 249(3):R9-10. PubMed ID: 8287911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
    Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dopamine D3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog.
    Yoshida N; Yoshikawa T; Hosoki K
    Life Sci; 1995; 57(21):PL347-50. PubMed ID: 7475938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
    Bancroft GN; Morgan KA; Flietstra RJ; Levant B
    Neuropsychopharmacology; 1998 Apr; 18(4):305-16. PubMed ID: 9509498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT.
    Levant B; Bancroft GN; Selkirk CM
    Synapse; 1996 Sep; 24(1):60-4. PubMed ID: 9046077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D3 receptor expression within the basal ganglia is not affected by Parkinson's disease.
    Hurley MJ; Stubbs CM; Jenner P; Marsden CD
    Neurosci Lett; 1996 Aug; 214(2-3):75-8. PubMed ID: 8878087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors.
    Aretha CW; Sinha A; Galloway MP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):609-13. PubMed ID: 7636720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isomeric selectivity at dopamine D3 receptors.
    Baldessarini RJ; Kula NS; McGrath CR; Bakthavachalam V; Kebabian JW; Neumeyer JL
    Eur J Pharmacol; 1993 Aug; 239(1-3):269-70. PubMed ID: 8223909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
    Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
    Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.